Caris Life Sciences vs iSpecimen .

Caris Life Sciences vs iSpecimen ., compared side by side on 20 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Caris Life Sciences is on 59/100 and iSpecimen . on 46/100.

Caris Life Sciences logo
Caris Life SciencesCaris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.
Try Caris Life Sciences
iSpecimen . logo
iSpecimen .Global marketplace connecting researchers with human biospecimens for life science research.
Try iSpecimen .

Where each one leads

Caris Life Sciences

  • our overall score: 59/100 against 46/100
  • agent readiness: 47/100 against 42/100
  • domain rating: 62/100 against 39/100
  • headcount: 1,659 against 20
  • funding raised: $700M against $1.0M
  • LinkedIn following: 77,698 against 2,812

iSpecimen .

Leads on none of the measures we hold for both companies.

At a glance

MeasureCaris Life SciencesiSpecimen .
What it isCaris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.Global marketplace connecting researchers with human biospecimens for life science research.
CategoryBiotech, MedTech, HealthTech, GenomicsBiotech, HealthTech, Genomics, Clinical Trials
Sells toBusiness modelB2BB2B
OfferingServicesMarketplace
Founded20082007
HeadquartersIrving, United StatesPlainsboro, United States
StatusActiveActive

Size, funding and growth

MeasureCaris Life SciencesiSpecimen .
Employees1,65920
Total funding$700M$1.0M
Latest roundSeries DSeed
Valuation$7.8BNot published
LinkedIn followers77,6982,812

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureCaris Life SciencesiSpecimen .
StartupHub scoreOur 0-100 rating59/10046/100
Traction60/10043/100
CommunityNot published8/100
Search visibility22/10034/100
Quality78/10058/100
Agent readinessHow well an AI agent can read and act on the siteD (47/100)D (42/100)
Domain ratingLink authority, 0-10062/10039/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureCaris Life SciencesiSpecimen .
HostingSelf ManagedNot detected
CDNNot detectedCloudflare
CMSWordPressWordPress
FrameworksNot detectedJquery, Bootstrap
AnalyticsGoogle Tag ManagerGoogle Tag Manager
Open sourceNoYes

Caris Life Sciences vs iSpecimen .: common questions

Which is better, Caris Life Sciences or iSpecimen .?

On our 0-100 score Caris Life Sciences rates higher (59/100 against 46/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 20 data points above: read the rows that match what you are buying for.

How do Caris Life Sciences and iSpecimen . compare on the numbers?

Caris Life Sciences leads on our overall score (59/100 against 46/100), agent readiness (47/100 against 42/100), domain rating (62/100 against 39/100), headcount (1,659 against 20), funding raised ($700M against $1.0M), LinkedIn following (77,698 against 2,812).

Read the full Caris Life Sciences review and pricing or the iSpecimen . review and pricing. You can also browse other Caris Life Sciences alternatives we track.